Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) - Total Assets
Based on the latest financial reports, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) holds total assets worth CN¥89.76 Billion CNY (≈ $13.13 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore 600332 current assets to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd - Total Assets Trend (1997–2025)
This chart illustrates how Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's total assets have evolved over time, based on quarterly financial data.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's total assets of CN¥89.76 Billion consist of 72.8% current assets and 27.2% non-current assets. Also see Guangzhou Baiyunshan Pharmaceutical Hold (600332) total market value for the company's overall valuation and market capitalisation.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 17.7% |
| Accounts Receivable | CN¥23.43 Billion | 27.7% |
| Inventory | CN¥13.14 Billion | 15.6% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥3.19 Billion | 3.8% |
| Goodwill | CN¥834.09 Million | 1.0% |
Asset Composition Trend (1997–2025)
This chart illustrates how Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 600332 stock price and chart for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's current assets represent 72.8% of total assets in 2025, an increase from 68.8% in 1997.
- Cash Position: Cash and equivalents constituted 17.7% of total assets in 2025, down from 21.8% in 1997.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, unchanged from 3.0% in 1997.
- Asset Diversification: The largest asset category is accounts receivable at 27.7% of total assets.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Competitors by Total Assets
Key competitors of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Selcuk Ecza Deposu Ticaret ve Sanayi AS
IS:SELEC
|
Turkey | TL80.93 Billion |
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$8.80 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Cyclopharm Ltd
AU:CYC
|
Australia | AU$46.10 Million |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
|
China | CN¥235.37 Billion |
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.60 | 1.54 | 1.66 |
| Quick Ratio | 1.29 | 1.24 | 1.39 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥24.30 Billion | CN¥19.56 Billion | CN¥19.87 Billion |
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd - Advanced Valuation Insights
This section examines the relationship between Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.88 |
| Latest Market Cap to Assets Ratio | 0.05 |
| Asset Growth Rate (YoY) | 3.5% |
| Total Assets | CN¥84.51 Billion |
| Market Capitalization | $4.44 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's assets below their book value (0.05x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's assets grew by 3.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (1997–2025)
The table below shows the annual total assets of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd from 1997 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥84.51 Billion ≈ $12.37 Billion |
+3.46% |
| 2024-12-31 | CN¥81.68 Billion ≈ $11.95 Billion |
+3.94% |
| 2023-12-31 | CN¥78.59 Billion ≈ $11.50 Billion |
+5.25% |
| 2022-12-31 | CN¥74.67 Billion ≈ $10.93 Billion |
+12.93% |
| 2021-12-31 | CN¥66.12 Billion ≈ $9.68 Billion |
+10.64% |
| 2020-12-31 | CN¥59.76 Billion ≈ $8.74 Billion |
+5.04% |
| 2019-12-31 | CN¥56.89 Billion ≈ $8.33 Billion |
+10.51% |
| 2018-12-31 | CN¥51.48 Billion ≈ $7.53 Billion |
+81.82% |
| 2017-12-31 | CN¥28.31 Billion ≈ $4.14 Billion |
+9.34% |
| 2016-12-31 | CN¥25.90 Billion ≈ $3.79 Billion |
+63.18% |
| 2015-12-31 | CN¥15.87 Billion ≈ $2.32 Billion |
+11.68% |
| 2014-12-31 | CN¥14.21 Billion ≈ $2.08 Billion |
+16.01% |
| 2013-12-31 | CN¥12.25 Billion ≈ $1.79 Billion |
+96.45% |
| 2012-12-31 | CN¥6.24 Billion ≈ $912.43 Million |
+28.53% |
| 2011-12-31 | CN¥4.85 Billion ≈ $709.89 Million |
+8.37% |
| 2010-12-31 | CN¥4.48 Billion ≈ $655.07 Million |
+6.02% |
| 2009-12-31 | CN¥4.22 Billion ≈ $617.88 Million |
+2.22% |
| 2008-12-31 | CN¥4.13 Billion ≈ $604.48 Million |
-33.45% |
| 2007-12-31 | CN¥6.21 Billion ≈ $908.27 Million |
+14.74% |
| 2006-12-31 | CN¥5.41 Billion ≈ $791.57 Million |
+6.11% |
| 2005-12-31 | CN¥5.10 Billion ≈ $746.01 Million |
-1.64% |
| 2004-12-31 | CN¥5.18 Billion ≈ $758.42 Million |
+10.11% |
| 2003-12-31 | CN¥4.71 Billion ≈ $688.79 Million |
+12.79% |
| 2002-12-31 | CN¥4.17 Billion ≈ $610.67 Million |
+12.87% |
| 2001-12-31 | CN¥3.70 Billion ≈ $541.02 Million |
+20.67% |
| 2000-12-31 | CN¥3.06 Billion ≈ $448.35 Million |
+1.25% |
| 1999-12-31 | CN¥3.03 Billion ≈ $442.83 Million |
+1.02% |
| 1998-12-31 | CN¥3.00 Billion ≈ $438.35 Million |
-0.11% |
| 1997-12-31 | CN¥3.00 Billion ≈ $438.83 Million |
-- |
About Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the pharmaceutical and healthcare industry in the People's Republic of China and internationally. The company operates through Modern Chinese Medicine Business, Chemical Pharmaceutical Technology Business, Natural Beverage Business, Pharmaceutical Commercial Business, and Other segments. It is involved in the research, develo… Read more